Immunome (IMNM) Interest Expenses (2019 - 2020)

Immunome (IMNM) has 8 years of Interest Expenses data on file, last reported at $184.9 million in Q1 2026.

• Quarterly Interest Expenses rose 69943.56% year-over-year to $184.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.9 million (up 25370.39% YoY) and the FY2025 annual result came in at $180.7 million, up 69.29% from the prior year.
• Interest Expenses climbed to $184.9 million in Q1 2026, from $5000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $184.9 million in Q1 2026 to a low of $5000.0 in Q4 2025.
• A 5-year average of $23.0 million and a median of $1.8 million in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2025 — Interest Expenses sank 98.33% — and 2026, when it jumped 69943.56%.
• Tracing IMNM's Interest Expenses over 5 years: stood at $292000.0 in 2022, then tumbled by 78.77% to $62000.0 in 2023, then soared by 383.87% to $300000.0 in 2024, then slumped by 98.33% to $5000.0 in 2025, then surged by 3698200.0% to $184.9 million in 2026.
• The last three Interest Expenses figures came in at $184.9 million (Q1 2026), $5000.0 (Q4 2025), and $41.8 million (Q3 2025), per Business Quant data.